argenx Initiates Second Cohort of Phase 2 ARDA Study of Empasiprubart in Multifocal Motor Neuropathy
Amsterdam, the Netherlands—June 20, 2023—argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...
Hosted on MSN
New blood test can spot deadly motor neurone disease with 100 per cent accuracy - would you take it?
The test was developed by researchers at the US-based not-for-profit Brain Chemistry Labs, who analysed 788 blood samples – roughly half from patients with the disease and half from people without it.
Results of a largescale collaborative project led by scientists at the Cedars-Sinai Medical Center, Los Angeles, and the University of California, Irvine (UCI), were published in the journal Neuron ...
Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP), share physical similarities but have been largely viewed as genetically distinct. However, ...
Rugby league player Jai Arrow’s recently announced diagnosis of motor neurone disease has again brought this devastating disease to public attention. Motor neurone disease is relatively rare, with ...
Rugby league player Jai Arrow's recently announced diagnosis of motor neuron disease has again brought this devastating disease to public attention. Motor neuron disease is relatively rare, with fewer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results